TENX
Tenax Therapeutics, Inc.
stockNASDAQ
At CloseOct 23, 2026 4:00:00 PM EDT
1.73USD-1.705%(-0.03)854,386
Pre-marketOct 23, 2026 9:26:30 AM EDT
1.7969USD+2.097%(+0.0369)
After-hoursOct 23, 2026 4:07:30 PM EDT
1.7128USD-0.994%(-0.0172)
Loading…
Loading…
64.74M
Healthcare
Biotechnology
CEO
Anthony DiTonno
HQ
Chapel Hill, NC, USA
Previous Close
$1.76
Beta
0.91
52-Week High
$19.40 2026-07-09
52-Week Low
$1.31 2026-08-10
SMA 50
$1.84
SMA 200
$10.40
Avg. Vol 10D
2.49M
Avg. Vol 30D
2.51M
Avg. Vol 90D
4.46M
Relative Vol
0.34
37.42M
26.47M
70.74%
7,182,126
27.13%
2.35
49%/51%
66.95%
58.07%
0.3200%
5,800,000
1,409
92,093
466,064
Nov 11, 2026 (17d)
Jan 3, 2024 · 1-for-80 (reverse)
-64.9M
-59.8
Oct 21, 2026
Sep 21, 2026
Monday 9/21 Insider Buying Report: TH, TENX · 
BNK Invest
Sep 17, 2026
Sep 15, 2026
Tenax Therapeutics CFO buys $10,981 in common stock · 
Investing.com
TENX Profile
tenax therapeutics is focused on developing and commercializing pharmaceutical products that improve outcomes for patients who require treatment for various critical care conditions. our development portfolio includes novel product candidates that have the potential to address various critical care conditions with high unmet medical need.
TENX Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.52 | 2026-10-19 | +13.82% | -1.639 |
| 1M | 1.81 | 2026-09-25 | -4.42% | 2.030 |
| 3M | 14.53 | 2026-07-24 | -88.09% | 1.439 |
| 6M | 14.30 | 2026-04-24 | -87.90% | 0.647 |
| 1Y | 7.39 | 2025-10-24 | -76.59% | 0.910 |
| 2Y | 4.75 | 2024-10-25 | -63.58% | — |
| 5Y | 2,400.00 | 2021-10-25 | -99.93% | 0.483 |
TENX Stock Summary
Tenax Therapeutics, Inc. (NASDAQ:TENX) stock price today is $1.73, and today's volume is 854,386. TENX is down 1.705% today. The 30 day average volume is 2.51M. TENX market cap is $64.74M with 37.42M shares outstanding.